Erasca (ERAS) Accumulated Depreciation & Amortization (2020 - 2026)
Erasca posted quarterly Accumulated Depreciation & Amortization of $13.3 million for Q1 2026, up 22.99% year-on-year from $10.8 million in Q1 2025, and up 5.13% on a QoQ basis from $12.7 million in Q4 2025.
Erasca (ERAS) has 7 years of Accumulated Depreciation & Amortization data on file, last reported at $13.3 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 22.99% year-over-year to $13.3 million; the trailing twelve-month figure through Mar 2026 stood at $13.3 million (up 22.99% YoY), and the FY2025 full-year result was $12.7 million, up 26.5% from the prior year.
- Accumulated Depreciation & Amortization for Q1 2026 stood at $13.3 million, up from $12.7 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $13.3 million in Q1 2026 and bottomed at $1.8 million in Q2 2022.
- The 5-year median for Accumulated Depreciation & Amortization is $8.2 million (2024), against an average of $7.6 million.
- The widest annual swing landed in 2023, when Accumulated Depreciation & Amortization jumped 197.83%; it then grew 22.99% in 2026.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $3.5 million in 2022, then jumped by 106.63% to $7.2 million in 2023, then surged by 38.4% to $10.0 million in 2024, then increased by 26.5% to $12.7 million in 2025, then advanced by 5.13% to $13.3 million in 2026.
- The last three Accumulated Depreciation & Amortization figures came in at $13.3 million (Q1 2026), $12.7 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Erasca | 4.21 Bn | 3.97 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.31 Mn |
| Mar 31, 2026 | 13.31 Mn |
| Dec 31, 2025 | 12.66 Mn |
| Dec 31, 2025 | 12.66 Mn |
| Sep 30, 2025 | 11.92 Mn |
| Sep 30, 2025 | 11.92 Mn |
| Jun 30, 2025 | 11.46 Mn |
| Jun 30, 2025 | 11.46 Mn |
| Mar 31, 2025 | 10.82 Mn |
| Mar 31, 2025 | 10.82 Mn |
| Dec 31, 2024 | 10.01 Mn |
| Dec 31, 2024 | 10.01 Mn |
| Sep 30, 2024 | 9.19 Mn |
| Sep 30, 2024 | 9.19 Mn |
| Jun 30, 2024 | 8.35 Mn |
| Jun 30, 2024 | 8.35 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Dec 31, 2023 | 7.23 Mn |
| Dec 31, 2023 | 7.23 Mn |
| Sep 30, 2023 | 6.29 Mn |
| Sep 30, 2023 | 6.29 Mn |
| Jun 30, 2023 | 5.35 Mn |
| Jun 30, 2023 | 5.35 Mn |
| Mar 31, 2023 | 4.39 Mn |
| Mar 31, 2023 | 4.39 Mn |
| Dec 31, 2022 | 3.50 Mn |
| Dec 31, 2022 | 3.50 Mn |
| Sep 30, 2022 | 2.57 Mn |
| Sep 30, 2022 | 2.57 Mn |
| Jun 30, 2022 | 1.80 Mn |
| Jun 30, 2022 | 1.80 Mn |
| Mar 31, 2022 | 2.13 Mn |
| Mar 31, 2022 | 2.13 Mn |
| Dec 31, 2021 | 1.73 Mn |
| Dec 31, 2021 | 1.73 Mn |
| Sep 30, 2021 | 1.41 Mn |
| Sep 30, 2021 | 1.41 Mn |
| Jun 30, 2021 | 1.22 Mn |
| Jun 30, 2021 | 1.22 Mn |
| Dec 31, 2020 | 902,000.00 |
| Dec 31, 2020 | 902,000.00 |